{"id":"unchanged-dose","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Further research is needed to understand the underlying mechanism of unchanged dose.","oneSentence":"The exact mechanism of unchanged dose is not well-documented.","_ai_confidence":"low"},"_scrapedAt":"2026-03-27T23:37:25.829Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Marketed for various uses"}]},"trialDetails":[{"nctId":"NCT07303777","phase":"PHASE2","title":"Efficacy, Safety, and PopPK Profile of ABP-745 in Patients With Atherosclerosis","status":"NOT_YET_RECRUITING","sponsor":"Atom Therapeutics Co., Ltd","startDate":"2026-04","conditions":"Atherosclerosis Cardiovascular Disease, ASCVD, ASCVD Management","enrollment":200},{"nctId":"NCT06284486","phase":"PHASE1, PHASE2","title":"A Multi-Site Break Through Cancer Trial: Phase II Study Investigating Dual Inhibition of BCL2 and Menin in AML MRD Using the Combination of Venetoclax and Revumenib","status":"RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2024-09-23","conditions":"Acute Myeloid Leukemia","enrollment":8},{"nctId":"NCT07428070","phase":"NA","title":"Contextually Enriched Individualized Exercise Versus Contextually Fixed Exercise for Rotator Cuff-Related Shoulder Pain","status":"NOT_YET_RECRUITING","sponsor":"Istanbul Nisantasi University","startDate":"2026-04-06","conditions":"Rotator Cuff Related Shoulder Pain, Shoulder Pain, Rotator Cuff Injuries","enrollment":72},{"nctId":"NCT04817761","phase":"PHASE2, PHASE3","title":"SPARK-ALL: Calaspargase Pegol in Adults With ALL","status":"TERMINATED","sponsor":"Institut de Recherches Internationales Servier","startDate":"2021-07-07","conditions":"Acute Lymphoblastic Leukemia","enrollment":42},{"nctId":"NCT07385664","phase":"PHASE2","title":"Neoadjuvant Chemoimmunotherapy or Chemoradiotherapy in ESCC","status":"NOT_YET_RECRUITING","sponsor":"Ji Yongling","startDate":"2026-01-28","conditions":"Resectable Esophageal Cancer","enrollment":66},{"nctId":"NCT07385001","phase":"PHASE1, PHASE2","title":"A Prospective, Multicenter, Phase Ib/II Trial of Ivonescimab (AK112) Combined With Albumin-Paclitaxel and Cisplatin as Neoadjuvant Therapy for ESCC","status":"RECRUITING","sponsor":"Tang-Du Hospital","startDate":"2026-01-28","conditions":"Esophageal Squamous Cell Carcinoma, Ivonescimab, Neoadjuvant","enrollment":45},{"nctId":"NCT04481555","phase":"PHASE4","title":"Eosinophil-guided Reduction of Inhaled Corticosteroids","status":"COMPLETED","sponsor":"Chronic Obstructive Pulmonary Disease Trial Network, Denmark","startDate":"2021-06-28","conditions":"COPD, Inhaled Corticosteroid, Azithromycin","enrollment":444},{"nctId":"NCT07354906","phase":"","title":"Upadacitinib in Giant Cell Arteritis (GCA) With Active Large-vessel Involvement.","status":"NOT_YET_RECRUITING","sponsor":"Groupe français d'étude des Maladies Inflammatoires de loeil","startDate":"2026-03-01","conditions":"Giant Cell Arteritis (GCA)","enrollment":80},{"nctId":"NCT07342790","phase":"NA","title":"Artificial Intelligence Clinical Decision","status":"NOT_YET_RECRUITING","sponsor":"Cairo University","startDate":"2026-02-01","conditions":"Myofacial Pain Syndrome, Clinical Decision Support","enrollment":70},{"nctId":"NCT07206277","phase":"NA","title":"Fibroscan to Guide Post Transplant Immunosuppression Minimization","status":"RECRUITING","sponsor":"University of Alberta","startDate":"2025-12-01","conditions":"Immunosuppression","enrollment":50},{"nctId":"NCT02494700","phase":"PHASE2","title":"Ultra Low Dose Orbital Radiation Therapy in Treating Patients With Stage I-IV Indolent B-cell Lymphoma or Mantle Cell Lymphoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2015-07-06","conditions":"Ann Arbor Stage I B-Cell Non-Hodgkin Lymphoma, Ann Arbor Stage I Grade 1 Follicular Lymphoma, Ann Arbor Stage I Grade 2 Follicular Lymphoma","enrollment":50},{"nctId":"NCT05740371","phase":"PHASE4","title":"Safety of Argatroban Infusion in Conduction Disturbances","status":"COMPLETED","sponsor":"Tanabe Pharma GmbH","startDate":"2017-04-18","conditions":"Stable Coronary Artery Disease (CAD), Unstable Angina (Troponin Negative)","enrollment":50},{"nctId":"NCT03326310","phase":"PHASE1","title":"Selumetinib and Azacitidine in High Risk Chronic Blood Cancers","status":"RECRUITING","sponsor":"University of Chicago","startDate":"2018-09-04","conditions":"Chronic Myeloid Leukemia, Myelofibroses","enrollment":18},{"nctId":"NCT03534947","phase":"PHASE2","title":"A Study to Evaluate Neoadjuvant Sonidegib Followed by Surgery or Imiquimod in the Management of Basal Cell Carcinoma","status":"COMPLETED","sponsor":"Melanoma Institute Australia","startDate":"2019-07-23","conditions":"Basal Cell Carcinoma, Basal Cell Carcinoma of Skin, Site Unspecified, Skin Cancer","enrollment":16},{"nctId":"NCT06998966","phase":"NA","title":"Optimizing Proton Pump Inhibitors (PPI) Prescribing With EHR-Based Decision Support","status":"RECRUITING","sponsor":"University of California, Los Angeles","startDate":"2026-01","conditions":"Prescribing Patterns, Physician, Physician's Practice Patterns, Drug Utilization Review","enrollment":372},{"nctId":"NCT05264506","phase":"PHASE3","title":"Contraceptive Efficacy and Safety of NOMAC-E2 Combined Oral Contraceptive","status":"TERMINATED","sponsor":"Organon and Co","startDate":"2022-02-17","conditions":"Contraception","enrollment":3055},{"nctId":"NCT05625386","phase":"NA","title":"Dual-target, High-dose TMS for PD Patients With FOG","status":"TERMINATED","sponsor":"Anhui Medical University","startDate":"2022-12-22","conditions":"Transcranial Magnetic Stimulation, Freezing of Gait","enrollment":64},{"nctId":"NCT04742751","phase":"PHASE2","title":"An Open-Label Pilot Intervention Trial to Prevent Diabetes in Prediabetic Adult Survivors of Childhood Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"St. Jude Children's Research Hospital","startDate":"2022-03-02","conditions":"PreDiabetes, Adult Children","enrollment":96},{"nctId":"NCT06261060","phase":"PHASE2","title":"Low-Dose Sirolimus to Increase Hematopoietic Function in Patients With RUNX1 Familial Platelet Disorder","status":"RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2024-06-20","conditions":"Familial Platelet Disorder, Hematopoietic","enrollment":6},{"nctId":"NCT03524430","phase":"NA","title":"RNA Disruption Assay (RDA)-Breast Cancer Response Evaluation for Individualized Therapy","status":"RECRUITING","sponsor":"Rna Diagnostics Inc.","startDate":"2018-04-26","conditions":"Breast Neoplasm Female","enrollment":801},{"nctId":"NCT04327388","phase":"PHASE3","title":"Sarilumab COVID-19","status":"COMPLETED","sponsor":"Sanofi","startDate":"2020-03-28","conditions":"Corona Virus Infection","enrollment":420},{"nctId":"NCT07138014","phase":"PHASE2","title":"FHND1002 for ALS Treatment: Phase 2","status":"NOT_YET_RECRUITING","sponsor":"Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd.","startDate":"2025-10-01","conditions":"Amyotrophic Lateral Sclerosis (ALS)","enrollment":180},{"nctId":"NCT07121751","phase":"PHASE4","title":"Optimal Stimulation of Hypo-responders Undergoing in Vitro Fertilization (IVF)","status":"NOT_YET_RECRUITING","sponsor":"Dunamenti REK Istenhegyi IVF Center","startDate":"2025-09-01","conditions":"Hypo-responder, Infertility (IVF Patients), OVARIAN STIMULATION","enrollment":150},{"nctId":"NCT07113015","phase":"NA","title":"A Study Comparing Propranolol and Amantadine for Reducing Tremors in People With Parkinson's Disease","status":"COMPLETED","sponsor":"Multan Medical And Dental College","startDate":"2024-07-05","conditions":"Parkinson Disease (PD), Tremor","enrollment":220},{"nctId":"NCT04891640","phase":"NA","title":"Biologic Abatement and Capturing Kids' Outcomes and Flare Frequency in Juvenile Spondyloarthritis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Children's Hospital of Philadelphia","startDate":"2021-11-11","conditions":"Juvenile Spondyloarthritis","enrollment":164},{"nctId":"NCT04255693","phase":"NA","title":"Real-life Study of Changes of Gastroesophageal Reflux Disease Manifestations Due to Behavioural and Diet Adherence","status":"RECRUITING","sponsor":"Federal State Budgetary Scientific Institution \"Federal Research Centre of Nutrition, Biotechnology","startDate":"2020-01-31","conditions":"Gastroesophageal Reflux Disease, GERD, Gastroesophageal Erosion","enrollment":150},{"nctId":"NCT07096115","phase":"NA","title":"ED90 of Teglidine for Suppressing LMA Insertion Response in the Elderly","status":"NOT_YET_RECRUITING","sponsor":"The First People's Hospital of Lianyungang","startDate":"2025-09-01","conditions":"Urological Surgery","enrollment":45},{"nctId":"NCT06947811","phase":"PHASE1, PHASE2","title":"A Study of Almonertinib Combined With Palbociclib in Patients With Advanced Solid Tumors Harboring KRAS Mutations","status":"RECRUITING","sponsor":"Sun Yat-sen University","startDate":"2025-06-09","conditions":"EGFR Tyrosine Kinase Inhibitors Plus Cyclin-dependent Kinase 4/6 Inhibitor","enrollment":71},{"nctId":"NCT05878795","phase":"NA","title":"Written Exposure Therapy for Suicide Prevention","status":"RECRUITING","sponsor":"Boston University","startDate":"2024-08-20","conditions":"Suicide, Attempted, Suicide Threat","enrollment":160},{"nctId":"NCT06987097","phase":"NA","title":"Ambrisentan for Early Low-Risk Pulmonary Arterial Hypertension","status":"NOT_YET_RECRUITING","sponsor":"Nanjing First Hospital, Nanjing Medical University","startDate":"2025-05-15","conditions":"Pulmonary Arterial Hypertension (PAH)","enrollment":410},{"nctId":"NCT02418585","phase":"PHASE3","title":"A Study to Evaluate the Efficacy, Safety, and Tolerability of Flexible Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant Depression","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2015-08-07","conditions":"Treatment-resistant Depression","enrollment":236},{"nctId":"NCT05741008","phase":"NA","title":"Clincal Study of Reduced Target Radiotherapy in Nasopharyngeal Carcinoma","status":"COMPLETED","sponsor":"First Affiliated Hospital of Kunming Medical University","startDate":"2023-01-01","conditions":"Toxicity Due to Radiotherapy, Nasopharyngeal Carcinoma","enrollment":20},{"nctId":"NCT04141644","phase":"PHASE1","title":"Safety and Efficacy of Combination Osimertinib and Ipilimumab in Patients w EGFR Mutated NSCLC","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Utah","startDate":"2020-08-20","conditions":"Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor (Disorder)","enrollment":24},{"nctId":"NCT06788314","phase":"PHASE2","title":"A Study of Enalapril in Treatment of Venous Malformations","status":"RECRUITING","sponsor":"Oslo University Hospital","startDate":"2025-02-01","conditions":"Venous Malformation, Pain, Quality of Life","enrollment":12},{"nctId":"NCT06906224","phase":"EARLY_PHASE1","title":"Effects of Buspirone Combined With Clozapine","status":"COMPLETED","sponsor":"Chuanfu Song","startDate":"2022-05-01","conditions":"Schizophrenia","enrollment":46},{"nctId":"NCT06901622","phase":"PHASE2","title":"Camrelizumab and Chemotherapy With or Without Anlotinib as First-line Treatment for Advanced Gallbladder Cancer and Extrahepatic Cholangiocarcinoma","status":"ENROLLING_BY_INVITATION","sponsor":"The First Affiliated Hospital of Zhengzhou University","startDate":"2024-11-08","conditions":"Gallbladder Cancer and Extrahepatic Cholangiocarcinoma","enrollment":50},{"nctId":"NCT05060991","phase":"PHASE4","title":"Impact of Immunosuppression Adjustment on COVID-19 Vaccination Response in Kidney Transplant Recipients","status":"RECRUITING","sponsor":"University of California, Davis","startDate":"2021-09-24","conditions":"COVID-19, Immunosuppression, Vaccine Response Impaired","enrollment":50},{"nctId":"NCT05369975","phase":"PHASE3","title":"Efficacy and Safety in Imlifidase Desensitized Kidney Tx Patients, Including Two Non-Comparative Reference Cohorts","status":"ACTIVE_NOT_RECRUITING","sponsor":"Hansa Biopharma AB","startDate":"2022-04-19","conditions":"Kidney Transplantation in Highly Sensitized Patients","enrollment":225},{"nctId":"NCT06880289","phase":"PHASE2","title":"Chemo-Radiotherapy Boost Treatment Guided by Perfusion MRI on Hypoxic Zones in Head and Neck Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Regina Elena Cancer Institute","startDate":"2020-09-16","conditions":"Squamous Cell Tumors of the Head and Neck","enrollment":91},{"nctId":"NCT06415227","phase":"PHASE2","title":"The Impact of Vericiguat on Microvascular Function in Patients with Documented Vasospastic Angina Pectoris","status":"NOT_YET_RECRUITING","sponsor":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","startDate":"2025-04-01","conditions":"Vasospastic Angina","enrollment":55},{"nctId":"NCT06586320","phase":"NA","title":"Quantification of Parkinson's Disease Patients As a Biomarker for Classification, Prediction and Response to Treatment","status":"ENROLLING_BY_INVITATION","sponsor":"Stardots AB","startDate":"2025-02-06","conditions":"Parkinson Disease","enrollment":40},{"nctId":"NCT04495452","phase":"","title":"Precision Medicine in Anesthesia","status":"WITHDRAWN","sponsor":"University of Alabama at Birmingham","startDate":"2024-06-10","conditions":"Respiratory Depression","enrollment":""},{"nctId":"NCT05256706","phase":"NA","title":"SomaSignal Tests on Medical Management and Change in Risk in Patients With Diabetes","status":"COMPLETED","sponsor":"Emory University","startDate":"2022-02-03","conditions":"Diabetes Mellitus, Type 2","enrollment":143},{"nctId":"NCT04870359","phase":"NA","title":"Pre-emptive Treatments in Lupus Nephritis Patients With Serological Reactivation","status":"COMPLETED","sponsor":"The University of Hong Kong","startDate":"2016-04-21","conditions":"Lupus Nephritis","enrollment":49},{"nctId":"NCT06696248","phase":"PHASE2, PHASE3","title":"Carvedilol and Alverine in Portal Hypertension","status":"NOT_YET_RECRUITING","sponsor":"Shanghai Changzheng Hospital","startDate":"2024-11-15","conditions":"Hypertension, Portal","enrollment":30},{"nctId":"NCT04213274","phase":"PHASE2","title":"Study of the Efficacy and Safety of RPH-104 in Adult Subjects With Schnitzler Syndrome","status":"WITHDRAWN","sponsor":"R-Pharm Overseas, Inc.","startDate":"2023-05","conditions":"Schnitzler Syndrome, Urticarial Vasculitis With Monoclonal Immunoglobulin M Component, Schnitzler (Disorder)","enrollment":""},{"nctId":"NCT06683703","phase":"PHASE2","title":"Utidelone Injection Combined with Bevacizumab Injection for Non-small Cell Lung Cancer Patients with Brain Metastases","status":"NOT_YET_RECRUITING","sponsor":"Beijing Biostar Pharmaceuticals Co., Ltd.","startDate":"2024-12-01","conditions":"Non-small Cell Lung Cancer Patients with Brain Metastases","enrollment":118},{"nctId":"NCT04292912","phase":"PHASE1","title":"A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GSK2798745 in Participants With Diabetic Macular Edema","status":"TERMINATED","sponsor":"GlaxoSmithKline","startDate":"2020-09-07","conditions":"Macular Edema","enrollment":16},{"nctId":"NCT02459574","phase":"NA","title":"Ablation Verses Anti-arrhythmic Therapy for Reducing All Hospital Episodes From Recurrent Atrial Fibrillation","status":"COMPLETED","sponsor":"Imperial College London","startDate":"2015-05-01","conditions":"Heart Failure, Recurrent Atrial Fibrillation","enrollment":321},{"nctId":"NCT06618937","phase":"PHASE4","title":"Toward Personalized Medicine to Guide Drug Withdrawal in Children with Juvenile Idiopathic Arthritis in Clinical Remission","status":"NOT_YET_RECRUITING","sponsor":"Istituto Giannina Gaslini","startDate":"2025-01-01","conditions":"Juvenile Idiopathic Arthritis (JIA)","enrollment":166},{"nctId":"NCT05824923","phase":"PHASE3","title":"A Trial to Evaluate the Safety and Efficacy of Pulmonary Artery Denervation for the Treatment of Pulmonary Hypertension Associated With Left Heart Failure","status":"RECRUITING","sponsor":"Pulnovo Medical (Wuxi) Co., Ltd.","startDate":"2023-08-14","conditions":"Pulmonary Hypertension, Heart Failure With Reduced Ejection Fraction, Hypertension","enrollment":264},{"nctId":"NCT06558539","phase":"PHASE3","title":"Tibial Nerve Stimulation for Post-BPH Overactive Bladder","status":"NOT_YET_RECRUITING","sponsor":"Qing Yuan","startDate":"2024-09","conditions":"Persistent Overactive Bladder Symptoms Post Benign Prostatic Hyperplasia Surgery","enrollment":90},{"nctId":"NCT06337994","phase":"PHASE3","title":"Memantine Hydrochloride for Treatment of Cognitive Dysfunction Due to Traumatic Brain Injury","status":"COMPLETED","sponsor":"Assiut University","startDate":"2024-01-01","conditions":"Treatment of Cognitive Deficits After Traumatic Brain Injury","enrollment":60},{"nctId":"NCT06188663","phase":"PHASE2","title":"SalT Supplementation in Older Adults With Orthostatic Intolerance Disorders","status":"RECRUITING","sponsor":"University of Galway","startDate":"2024-07-09","conditions":"Orthostatic Hypotension","enrollment":48},{"nctId":"NCT03754348","phase":"NA","title":"Microglial Activation in Narcolepsy Type 1 and Kleine-Levin Syndrome: Positron Emission Tomography (PET) Study in [18F] DPA-714","status":"COMPLETED","sponsor":"University Hospital, Montpellier","startDate":"2019-01-15","conditions":"Narcolepsy 1, Kleine-Levin Syndrome","enrollment":78},{"nctId":"NCT05243602","phase":"PHASE4","title":"BFTAF Elderly Switch Study","status":"COMPLETED","sponsor":"University of Nairobi","startDate":"2022-02-01","conditions":"HIV-1-infection","enrollment":520},{"nctId":"NCT05471544","phase":"PHASE3","title":"Effectiveness, Feasibility and Acceptability of Seasonal Malaria Chemoprevention in Aweil South County in South Sudan","status":"UNKNOWN","sponsor":"Malaria Consortium","startDate":"2022-07-18","conditions":"Malaria","enrollment":3575},{"nctId":"NCT04904081","phase":"PHASE3","title":"Feasibility of Use of Indocyanine Green in Pediatric Colorectal Surgery","status":"RECRUITING","sponsor":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","startDate":"2021-06-16","conditions":"Hirschsprung Disease, Anorectal Malformations","enrollment":12},{"nctId":"NCT03258723","phase":"PHASE4","title":"Diabetes Prevention With Lifestyle Intervention and Metformin Escalation","status":"TERMINATED","sponsor":"Yale University","startDate":"2018-07-30","conditions":"Diabetes","enrollment":114},{"nctId":"NCT04794491","phase":"PHASE4","title":"An Interventional Safety Switch Study (Segue Study) of XYWAV in Narcolepsy","status":"COMPLETED","sponsor":"Jazz Pharmaceuticals","startDate":"2021-03-22","conditions":"Narcolepsy","enrollment":62},{"nctId":"NCT01815957","phase":"NA","title":"Impact of Ranolazine on Coronary Microcirculatory Resistance","status":"COMPLETED","sponsor":"University of New Mexico","startDate":"2012-05","conditions":"Coronary Microcirculation, Coronary Artery Disease, Myocardial Disease","enrollment":7},{"nctId":"NCT05544071","phase":"NA","title":"the Safety and Effectiveness of Precise rTMS Based on Neuroimaging in the Treatment of Adolescent Depression With Anhedoniadepression With Anhedonia","status":"UNKNOWN","sponsor":"Xijing Hospital","startDate":"2023-02-12","conditions":"Major Depressive Disorder, Repetitive Transcranial Magnetic Stimulation","enrollment":88},{"nctId":"NCT05478954","phase":"PHASE4","title":"Chemoprevention Efficacy Study in Burkina Faso","status":"UNKNOWN","sponsor":"Malaria Consortium","startDate":"2022-07-15","conditions":"Malaria","enrollment":800},{"nctId":"NCT02408120","phase":"PHASE4","title":"Benefits of Insulin Supplementation for Correction of Hyperglycemia in Patients With Type 2 Diabetes","status":"COMPLETED","sponsor":"Emory University","startDate":"2015-10","conditions":"Diabetes Mellitus, Type 2","enrollment":226},{"nctId":"NCT05328440","phase":"PHASE2","title":"Treatment of Dalpiciclib Combined With Pyrotinib for Trastuzumab-sensitive HER2+ Advanced Breast Cancer(DAP-Her-02)","status":"UNKNOWN","sponsor":"Henan Cancer Hospital","startDate":"2022-05-20","conditions":"Breast Neoplasms","enrollment":120},{"nctId":"NCT05979896","phase":"PHASE4","title":"Chemoprevention Efficacy Study Nigeria","status":"UNKNOWN","sponsor":"Malaria Consortium","startDate":"2023-07-28","conditions":"Malaria","enrollment":800},{"nctId":"NCT00488605","phase":"PHASE3","title":"H-9926-LCH III: Treatment Protocol of the Third International Study for Langerhans Cell Histiocytosis","status":"WITHDRAWN","sponsor":"University of New Mexico","startDate":"2023-08-01","conditions":"Leukemia","enrollment":""},{"nctId":"NCT05960617","phase":"PHASE2","title":"Efficacy and Safety of Empagliflozin in GSD-Ib Patients","status":"UNKNOWN","sponsor":"Xinhua Hospital, Shanghai Jiao Tong University School of Medicine","startDate":"2023-07-15","conditions":"Glycogen Storage Disease Type IB","enrollment":10},{"nctId":"NCT05671315","phase":"NA","title":"A Prospective Study to Evaluate Peginterferon in Reducing the Incidence of HCC in CHB Patients","status":"RECRUITING","sponsor":"Qing XIe","startDate":"2019-07-03","conditions":"Chronic Hepatitis B, Intermediate to High Risk of HCC","enrollment":267},{"nctId":"NCT04354896","phase":"PHASE4","title":"The Effect of Thyroid Hormone Therapy on Muscle Mass and Function in Older Adults With Subclinical Hypothyroidism","status":"COMPLETED","sponsor":"Insel Gruppe AG, University Hospital Bern","startDate":"2014-05","conditions":"Subclinical Hypothyroidism, Sarcopenia","enrollment":322},{"nctId":"NCT05127018","phase":"PHASE1, PHASE2","title":"Higher Doses of Botulinum Toxin in the Treatment of Gummy Smile","status":"COMPLETED","sponsor":"Peking University","startDate":"2019-11-20","conditions":"Smiling, Botulinum Toxins, Type A","enrollment":33},{"nctId":"NCT05218343","phase":"NA","title":"An Intuitive, Non-intrusive, Approach to Reduce Patient Harm From Inappropriate Dosing of High-risk Drugs in Older Adult Patients Across an Urban Safety Net Hospital System","status":"COMPLETED","sponsor":"Icahn School of Medicine at Mount Sinai","startDate":"2022-02-16","conditions":"Potentially Inappropriate Medications","enrollment":8640},{"nctId":"NCT02894398","phase":"PHASE2","title":"Study in Women With Advanced Breast Cancer Receiving Palbociclib With AI or Fulvestrant","status":"COMPLETED","sponsor":"iOMEDICO AG","startDate":"2016-09-06","conditions":"Breast Cancer, Hormone Receptor Positive Tumor, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast","enrollment":388},{"nctId":"NCT03540212","phase":"PHASE2, PHASE3","title":"Clinical Pharmacokinetics of Daclatasvir/Sofosbuvir in Adolescents With Hepatitis C Virus","status":"UNKNOWN","sponsor":"Ain Shams University","startDate":"2017-12-10","conditions":"Chronic HCV Infection","enrollment":50},{"nctId":"NCT04326764","phase":"PHASE3","title":"Panobinostat Maintenance After HSCT fo High-risk AML and MDS","status":"TERMINATED","sponsor":"Goethe University","startDate":"2018-07-24","conditions":"Acute Myeloid Leukaemia (AML), Myelodysplastic Syndromes (MDS)","enrollment":52},{"nctId":"NCT02653079","phase":"","title":"Immunophenotyping From Blood of Patients Suffering From Chronic Degenerating Joint Diseases and Receiving LDRT","status":"RECRUITING","sponsor":"University of Erlangen-Nürnberg Medical School","startDate":"2016-06","conditions":"Chronic Inflammatory Disorder","enrollment":250},{"nctId":"NCT03111914","phase":"NA","title":"Applications of Dual Energy CT in Patients With Osseous Metastases From Castrate-resistant Prostate Cancer","status":"TERMINATED","sponsor":"Duke University","startDate":"2017-07-03","conditions":"Dual Energy CT (DECT), Prostate Cancer","enrollment":7},{"nctId":"NCT04183868","phase":"PHASE4","title":"Effects of empagliFlozin on myocardIal metabOlic Rate of glucosE Estimated Through 18FDG PET (FIORE Study)","status":"COMPLETED","sponsor":"University of Catanzaro","startDate":"2016-04","conditions":"Type 2 Diabetes, Cardiovascular Risk Factor","enrollment":26},{"nctId":"NCT05682755","phase":"PHASE1, PHASE2","title":"Chidamide Prevents Recurrence of High-risk AML After Allo-HSCT","status":"RECRUITING","sponsor":"Sichuan University","startDate":"2022-12-22","conditions":"Leukemia, Myeloid, Acute","enrollment":77},{"nctId":"NCT02607904","phase":"PHASE2","title":"An Open-label Extension Trial to Investigate Possible Drug-drug Interactions Between Stiripentol or Valproate and Cannabidiol in Patients With Epilepsy","status":"COMPLETED","sponsor":"Jazz Pharmaceuticals","startDate":"2016-12-15","conditions":"Epilepsy","enrollment":30},{"nctId":"NCT04505358","phase":"PHASE2","title":"Evaluate PU-AD in Subjects With Amyotrophic Lateral Sclerosis","status":"WITHDRAWN","sponsor":"Samus Therapeutics, Inc.","startDate":"2023-01","conditions":"Amyotrophic Lateral Sclerosis (ALS)","enrollment":""},{"nctId":"NCT04550130","phase":"NA","title":"Dose-Evaluation Study of the Efficacy and Safety of TLA Gut™ Leukapheresis Treatment in Patients With Ulcerative Colitis","status":"UNKNOWN","sponsor":"TLA, Targeted Immunotherapies AB","startDate":"2022-12","conditions":"Ulcerative Colitis (UC)","enrollment":12},{"nctId":"NCT05299047","phase":"PHASE2","title":"Fluoroscopic Anterior Approach Versus Ultrasound Guided Superior Hypogastric Plexus Neurolysis in Cancer Pelvic Pain","status":"UNKNOWN","sponsor":"Mansoura University","startDate":"2022-01-01","conditions":"Pain Cancer","enrollment":96},{"nctId":"NCT02088931","phase":"PHASE1","title":"Treg Adoptive Therapy for Subclinical Inflammation in Kidney Transplantation","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2014-03","conditions":"Late Complication From Kidney Transplant","enrollment":3},{"nctId":"NCT01093573","phase":"PHASE1, PHASE2","title":"Midostaurin and Azacitidine in Treating Elderly Patients With Acute Myelogenous Leukemia","status":"COMPLETED","sponsor":"Brenda Cooper, MD","startDate":"2009-07","conditions":"Untreated Adult Acute Myeloid Leukemia","enrollment":34},{"nctId":"NCT04585776","phase":"PHASE2","title":"A Study of LY900014 and Insulin Degludec in Participants With Type 1 Diabetes","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2020-10-30","conditions":"Type 1 Diabetes","enrollment":31},{"nctId":"NCT03350815","phase":"PHASE4","title":"Study Estimating the Clinical Difference Between 300 mg and 150 mg of Secukinumab Following Dose Escalation to 300 mg in Patients With Ankylosing Spondylitis","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2018-03-13","conditions":"Ankylosing Spondylitis","enrollment":322},{"nctId":"NCT02803918","phase":"PHASE1","title":"A Study on Safety, Pharmacokinetics and Pharmacodynamics of Lixisenatide in Pediatric Patients With Type 2 Diabetes Mellitus (T2DM)","status":"COMPLETED","sponsor":"Sanofi","startDate":"2017-05-17","conditions":"Type 2 Diabetes Mellitus","enrollment":23},{"nctId":"NCT05326490","phase":"PHASE3","title":"Study to Evaluate the Efficacy and Safety of PB-201 in Type 2 Diabetic Mellitus Patients With Poor Glycemic Control Via Metformin Hydrochloride Monotherapy","status":"UNKNOWN","sponsor":"PegBio Co., Ltd.","startDate":"2022-05-30","conditions":"Type 2 Diabetes Mellitus","enrollment":546},{"nctId":"NCT03434119","phase":"PHASE3","title":"Efficacy and Safety of Soliqua Versus Lantus in Ethnically/Racially Diverse Patients With Type 2 Diabetes Mellitus Inadequately Controlled on Basal Insulin and Oral Antidiabetic Agents","status":"TERMINATED","sponsor":"Sanofi","startDate":"2018-02-20","conditions":"Type 2 Diabetes Mellitus","enrollment":241},{"nctId":"NCT01817426","phase":"PHASE4","title":"Discontinuation of Infliximab Therapy in Patients With Crohn's Disease During Sustained Complete Remission","status":"COMPLETED","sponsor":"Copenhagen University Hospital at Herlev","startDate":"2013-01","conditions":"Crohn Disease","enrollment":115},{"nctId":"NCT02332655","phase":"PHASE1, PHASE2","title":"Cannabidiol Expanded Access Study in Medically Refractory Sturge-Weber Syndrome","status":"COMPLETED","sponsor":"Anne Comi, MD","startDate":"2014-12","conditions":"Sturge-Weber Syndrome","enrollment":5},{"nctId":"NCT05183594","phase":"NA","title":"Evaluate the Efficacy, Safety and Tolerability of TSUPPORT for Adults With Tourette Syndrome","status":"UNKNOWN","sponsor":"Tasly Pharmaceuticals, Inc.","startDate":"2022-03","conditions":"Tourette Syndrome","enrollment":10},{"nctId":"NCT04961229","phase":"PHASE4","title":"Booster Dose of COVID-19 Vaccine for Kidney Transplant Recipients Without Adequate Humoral Response","status":"UNKNOWN","sponsor":"dafna yahav","startDate":"2021-10","conditions":"COVID-19 Acute Respiratory Distress Syndrome, Immunosuppression","enrollment":504},{"nctId":"NCT02256462","phase":"PHASE4","title":"Pediatric Crohn's Disease AdalImumab Level-based Optimization Treatment (PAILOT) Trial","status":"COMPLETED","sponsor":"Schneider Children's Medical Center, Israel","startDate":"2015-05-01","conditions":"Crohn's Disease","enrollment":82},{"nctId":"NCT02516332","phase":"NA","title":"Exercise and Pharmacotherapy for Anxiety in Cardiac Patients","status":"COMPLETED","sponsor":"Duke University","startDate":"2015-12","conditions":"Anxiety, Cardiovascular Disease","enrollment":128},{"nctId":"NCT02005822","phase":"PHASE3","title":"Congenital Cytomegalovirus: Efficacy of Antiviral Treatment","status":"COMPLETED","sponsor":"Dr. Ann C.T.M. Vossen","startDate":"2013-10-22","conditions":"Congenital Cytomegalovirus Infection, Sensorineural Hearing Loss","enrollment":37},{"nctId":"NCT04833660","phase":"NA","title":"rTMS on Diabetic Peripheral Neuropathic Pain","status":"UNKNOWN","sponsor":"Min Cheol Chang","startDate":"2021-04-30","conditions":"Diabetic Peripheral Neuropathic Pain","enrollment":22},{"nctId":"NCT02607306","phase":"PHASE3","title":"A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide, Insulin Degludec and Liraglutide in Japanese Subjects With Type 2 Diabetes Mellitus.","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2015-11-18","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":819},{"nctId":"NCT04820543","phase":"PHASE4","title":"Effects of Dose and Injection Site for Gummy Smile Treatment With Botulinum Type A","status":"COMPLETED","sponsor":"Peking University","startDate":"2019-02-20","conditions":"Smiling, Botulinum Toxins, Type A","enrollment":55}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":31,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"unchanged dose","genericName":"unchanged dose","companyName":"Dunamenti REK Istenhegyi IVF Center","companyId":"dunamenti-rek-istenhegyi-ivf-center","modality":"Small molecule","firstApprovalDate":"","aiSummary":"The exact mechanism of unchanged dose is not well-documented. Used for Marketed for various uses.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}